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Abstract
Background: To assess the retinal sensitivity in obstructive sleep apnea hypopnea syndrome (OSAHS) patients
evaluated with standard automated perimetry (SAP). And to correlate the functional SAP results with structural
parameters obtained with optical coherence tomography (OCT).
Methods: This prospective, observational, case-control study consisted of 63 eyes of 63 OSAHS patients (mean age
51.7 ± 12.7 years, best corrected visual acuity ≥20/25, refractive error less than three spherical or two cylindrical
diopters, and intraocular pressure < 21 mmHg) who were enrolled and compared with 38 eyes of 38 age-matched
controls. Peripapillary retinal nerve fiber layer (RNFL) thickness was measured by Stratus OCT and SAP sensitivities
and indices were explored with Humphrey Field Analyzer perimeter. Correlations between functional and structural
parameters were calculated, as well as the relationship between ophthalmologic and systemic indices in OSAHS
patients.
Results: OSAHS patients showed a significant reduction of the sensitivity for superior visual field division (p = 0.034,
t-student test). When dividing the OSAHS group in accordance with the severity of the disease, nasal peripapillary
RNFL thickness was significantly lower in severe OSAHS than that in controls and mild-moderate cases (p = 0.031
and p = 0.016 respectively, Mann-Whitney U test). There were no differences between groups for SAP parameters.
We found no correlation between structural and functional variables. The central visual field sensitivity of the SAP
revealed a poor Pearson correlation with the apnea-hipopnea index (0.284, p = 0.024).
Conclusions: Retinal sensitivity show minor differences between healthy subjects and OSAHS. Functional
deterioration in OSAHS patients is not easy to demonstrate with visual field examination.
Keywords: Visual field, Automated perimetry exam, Optical coherence tomography, Obstructive sleep apnea
syndrome, OSAHS
Background
Obstructive sleep apnea-hypopnea syndrome (OSAHS)
is a disorder characterized by brief episodes of complete
or partial upper airway collapse during sleep. When
those apnea-hypopnea events sum five or more events
per hour, a pathological breathing status appears. Nu-
merous ophthalmological disorders seem to be associ-
ated with OSAHS, including floppy-eyelid syndrome or
central serous chorioretinopathy. Moreover, some au-
thors suggest that certain optic nerve (ON) disorders
such as papilledema, glaucoma or non-arteritic anterior
ischemic optic neuropathy showed an increased inci-
dence in the obstructive disease [1–10].
Changes in the retinal nerve fiber layer (RNFL) thick-
ness have been reported in OSAHS by multiple authors.
These alterations appear even in individuals in whom
glaucomatous neuropathy has been ruled out, proposing
therefore the breathing disease could be “per se” an
aggressive agent for the ON [11–16].
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Studies describing the progression of the most common
neuropathy in our specialty, glaucomatous neuropathy,
have contributed to establish a relationship between the
functional visual impairment and the structural damage of
the ON [17, 18]. Other pathologies, as sclerosis multiple,
also seem to have a good agreement and correlation
between abnormalities detected by standard automated
perimetry (SAP) and RNFL measurements, as Cheng et
al. found in eyes with optic neuritis secondary to this
cause [19].
The aim of this study was to investigate whether there
is a visual field (VF) functional deficit in OSAHS pa-
tients compared to healthy individuals. And to study if
there is a correlation between functional variables and
structural (OCT) variables in OSAHS.
Methods
Eighty OSAHS patients were consecutively recruited in
the Otolaryngology Department at the Hospital Miguel
Servet, in Zaragoza, Spain. All patients had a newly dis-
covered and previously untreated mild to severe OSAHS
according to clinical features and apnea–hypopnea index
(AHI) greater than 4. Before OSAHS was confirmed, pa-
tients completed a questionnaire concerning epidemio-
logical data and information about symptoms such as
loud snoring, observed apnea, or excessive daytime sleepi-
ness. The most common vascular risk factors were studied
and treated if necessary.
Patients were subsequently referred for an ophthalmo-
logical examination to the Ophthalmology Department
at the Hospital Clínico Lozano Blesa in Zaragoza, Spain,
between December 2010 and March 2012. Patients with
history of stroke with central apnea, chronic uveitis,
antiglaucomatous drug usage, optic neuropathy, ocular
trauma or surgeries were excluded from this study. After
appropriate information, written informed consent of all
subjects was obtained. The research followed the tenets
of the Declaration of Helsinki, and the protocol was
approved by the local Ethics Committee.
The control group included 40 age-matched healthy sub-
jects, who were recruited among relatives and employees at
the Hospital Lozano Blesa. Selection was made with Berlin
questionnaire (evaluating the functional signs of OSAHS,
86% sensitivity for diagnosis and 77% specificity) [20, 21].
Epidemiological data were collected and smoking habit and
vascular risk factors were treated in the same way.
All OSAHS and controls underwent a complete oph-
thalmologic examination, including best-corrected visual
acuity (BCVA), ocular motility, slit-lamp biomicroscopy,
Goldmann applanation tonometry, gonioscopy, Humphrey
automated VF, and OCT examination. Values of the right
eyes were selected for analysis except when they did
not fulfill the inclusion criteria; in this case, left eyes
were selected.
At least two reliable SAP were performed to minimize
the learning effect. VFs were evaluated with a Humphrey
Field Analyzer perimeter model 740i (Zeiss Humphrey
Systems, Dublin, CA) by using the 24–2 SITA fast strat-
egy, with a Goldman size III stimulus on a 31.5-apostilb
background. Near addition was added to the subject’s
refractive correction. If fixation losses were higher than
20% or false positive or false-negative rates were higher
than 15%, the test was repeated. Each perimetry was per-
formed on different days to avoid the fatigue effect and
the same experienced examiner conducted all scans.
OCT was performed with the Stratus OCT (Carl Zeiss
Meditec, Dublin, CA, USA) following 1% tropicamide in-
stillation. Only high-quality images were included. Each
patient underwent scans to measure peripapillary RNFL
thickness, which was automatically calculated by the fast
RNFL algorithm. We considered the overall thickness and
per quadrant.
Examiners were masked to the diagnosis. All partici-
pants had a BCVA of 20/30 or better, with a refractive
error lower than three spherical or two cylindrical diop-
ters. Intraocular pressure (IOP) > 21 mmHg, posterior
segment pathology or patients with media opacification
were excluded. Regarding VF, eyes with defects compat-
ible with glaucoma (nasal step, paracentral or arcuate
scotomas, or arcuate blind spot enlargement) with a pat-
tern standard deviation (PSD) significantly elevated be-
yond the 5% level and/or a Glaucoma Hemifield Test
outside normal limits were also excluded.
For comparison we used Humphrey global indices
such as mean deviation (MD) and PSD, and we also
calculated mean sensitivity (MS) recording each of the
threshold values in decibel scale. Sector MD was calcu-
lated by averaging the deviation values on total-deviation
plots for each sector. To investigate correspondence be-
tween structure and function, we used a more simplified
version of the topographic map obtained by Garway-
Heath [17], proposed by Cheng et al. [19]. Nevertheless,
we introduced some subtle variations on Cheng’s map,
like the use of all sensitivity points, including the blind
spot ones (Fig. 1).
Statistical analysis
Data analysis was performed by using Statistical Package
for Social Sciences software (version 19.0, Chicago, IL,
USA). Values were presented as mean ± standard devi-
ation, and expressed in microns for the peripapillary
RNFL thickness and in decibels for the VF sensitivities.
Qualitative differences between the studied variables
were assessed by using Pearson’s chi-squared test.
Differences between controls and OSAHS were tested
by Student’s-t test when normality and equality of vari-
ances were proved. If these conditions were not satisfied,
the non-parametric Mann-Whitney U test was used.
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In a second analysis, OSAHS sample was divided ac-
cording to severity into two groups: those with mild-
moderate OSAHS (group 1, AHI ≥5 and < 30) and those
with severe OSAHS (group 2, AHI ≥30). Both groups were
compared to controls. Quantitative differences between
the three groups were compared by using one-way
ANOVA test, once normality and homogeneity was
proved with Shapiro-Wilk and Levene’s tests. In the event
of breach of the homogeneity and normality assumption,
the non-parametric Kruskal-Wallis H test was applied. In
those cases where differences had been statistically signifi-
cant, two by two Scheffé comparison (after ANOVA test)
or Mann-Whitney U analysis (after Kruskal-Wallis H test)
were performed to know which groups were different.
The relationship between structural and functional
variables were analyzed by applying linear, logarithmic,
inverse, quadratic and cubic models in OSAHS and in
controls separately. In addition, Pearson’s correlation co-
efficient between AHI and VF indices in OSAHS were
evaluated. A p value < 0.05 was considered statistically
significant.
Results
Of 80 consecutive OSAHS who accepted to participate,
63 patients (66.9%) were included in the study (51 right
eyes and 12 left eyes), whereas 36 patients (33.1%) were
excluded. Twenty-nine patients had a mild-moderate
OSAHS (46%), and the other 34 patients (54%) had a
severe disorder.
In the control group, 40 individuals classified as “low
risk subjects” by the Berlin questionnaire were exam-
ined. Two patients were excluded after exclusion criteria
application, and finally the group was composed of 37
right eyes and one left eye of 38 healthy subjects.
Age showed no statistically significant difference be-
tween groups, neither when dividing the OSAHS group
according to its severity. In OSAHS group, although more
men than women were enrolled, we did not consider this
difference because gender has no effect on RNFL thick-
ness as previously mentioned [22]. Body mass index was
not matched, and was higher in OSAHS than that in con-
trols (p < 0.001). Nevertheless, no significant differences in
vascular risk factors (hypertension, diabetes and dyslipid-
emia) and prevalence of smoking habit between cases and
controls were found.
Table 1 shows the results of IOP, peripapillary RNFL
thickness and VF parameters in controls and OSAHS.
Differences between groups were just found in the VF
superior division, sensitivity was higher in healthy sub-
jects than in OSAHS ones. MD showed results close to
the statistical significance.
Table 2 shows the results of IOP and peripapillary
RNFL thickness measurements by dividing OSAHS patients
according to severity. IOP showed no differences between
groups. Nasal quadrant of peripapillary RNFL thickness
showed a difference between categories. Thus, nasal RNFL
thickness was significantly lower in severe OSAHS than that
in moderate OSAHS (p = 0.031, Mann-Whitney U test).
Moreover, nasal RNFL thickness was thinner in severe
OSAHS versus controls (p = 0.016, Mann-Whitney U test).
Humphrey VF results showed no differences between
controls and severity of OSAHS groups (Table 3). VF
superior division showed a nonstatistical trend (0.08,
ANOVA test). This difference was not statistically
significant when we applied a multiple comparison test:
p = 0.11 in controls versus mild-moderates; p = 0.295 in
controls versus severes; and p = 0.834 in mild-moderates
versus severes (Scheffé post hoc test).
Fig. 1 Corresponding areas: visual field – optic nerve. a Cheng et al. map. Correlation between OCT RNFL quadrants and corresponding sectors
on SAP 24–2. b Topographical division on map of absolute retinal sensitivity used in our study, based on the topographic map proposed by
Cheng et al. Note the inclusion of the points corresponding to the blind spot in the central division average sensitivity calculations
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Table 2 Comparison of IOP and RNFL thickness measurements between controls, mild, moderate and severe OSAHS patients
Normality S-W Homogeneity Levene Test ANOVA/Kruskall W
Severity Average ± SD
[Min-Max]
p-value p-value F p-value
IOP Control (N = 38) 15.1 ± 2.1 [10–19] 0.222 0.22 0.73 0.48*
Mild-Moderate (N = 29) 15.6 ± 2.6 [11–22] 0.138
Severe (N = 34) 15.8 ± 3 [10–21] 0.135
Average RNFL Control (N = 38) 98.6 ± 10.9 [68.9–117.5] 0.617 0.78 2.13 0.12*
Mild-Moderate (N = 29) 101.8 ± 10.4 [82.2–125.3] 0.651
Severe (N = 34) 96.3 ± 10.1 [76–118] 0.684
RNFL superior quadrant Control (N = 38) 119.9 ± 19.3 [69–159] 0.914 0.13 0.58 0.56*
Mild-Moderate (N = 29) 124.5 ± 13.6 [85–160] 0.215
Severe (N = 34) 122 ± 18.4 [90–162] 0.695
RNFL nasal quadrant Control (N = 38) 80.1 ± 16.9 [52–126] 0.126 0.21 / 0.029†
Mild-Moderate (N = 29) 79.0 ± 17.0 [47–117] 0.533
Severe (N = 34) 71.3 ± 14.1 [49–115] 0.05
RNFL inferior quadrant Control (N = 38) 124.2 ± 13.7 [93–160] 0.829 0.07 1.92 0.15*
Mild-Moderate (N = 29) 128.1 ± 19.9 [91–166] 0.688
Severe (N = 34) 120.2 ± 13.9 [92–163] 0.398
RNFL temporal quadrant Control (N = 38) 70.2 ± 12.3 [47–93] 0.410 0.91 1.34 0.27*
Mild-Moderate (N = 29) 75.3 ± 12.6 [51–101] 0.910
Severe (N = 34) 71.6 ± 13.5 [45–100] 0.272
IOP intraocular pressure, RNFL retinal nerve fiber layer, S-W Shapiro-Wilk, Kruskall W Kruskall Wallis, N number of eyes
*ANOVA test
†Kruskal Wallis (p value < 0.05)
Table 1 Comparison of IOP, RNFL thickness and Humphrey VF parameters between controls and OSAHS patients
Variable CONTROLS (N = 38) OSAHS (N = 63) p-value
IOP 15.1 ± 2.1 [10–19] 15.7 ± 2.8 [10–22] 0.218*
Average RNFL 98.60 ± 10.95 [68.86–117.54] 98.79 ± 10.55 [76–125.33] 0.932*
RNFL superior
Quadrant
119.89 ± 19.32 [69–159] 123.17 ± 16.35 [85–162] 0.385*
RNFL nasal
Quadrant
80.08 ± 16.92 [52–126] 74.86† ± 15.86 [47–117] 0.128*
RNFL inferior
Quadrant
124.21 ± 13.71 [93–160] 123.84 ± 17.29 [91–166] 0.906*
RNFL temporal
Quadrant
70.24 ± 12.33 [47–93] 73.30 ± 13.14 [45–101] 0.241*
Average sensitivity 29.74 ± 1.31† [26.59–31.87] 29.3 ± 1.46 [23.9–32.03] 0.097†
VF superior division 30.05 ± 1.54 [27.04–32.91] 29.37 ± 1.56 [25.08–32.3] 0.034*
VF inferior division 31.13 ± 1.43† [27.28–32.91] 30.89 ± 1.37 [26.57–33.66] 0.211†
VF central division 27.59 ± 1.44 [23.28–31.14] 27.43 ± 1.83 [24–32.14] 0.406†
VF temporal división 30.19 ± 2.0 [25.67–33.33] 29.49† ± 2.75 [13–33] 0.145†
VFI 99.16† ± 0.85 [97–100] 98.97† ± 0.983 [96–100] 0.361†
MD 0.04 ± 1.13 [(− 2.78) – 1.79] −0.389 ± 1.2 [(− 3.75) – 1.65] 0.07*
PSD 1.52† ± 0.3 [0.96–2.64] 1.61† ± 0.67 [0.9–5.93] 0.955†
IOP intraocular pressure, RNFL retinal nerve fiber layer, VF visual field, VFI visual field index, MD mean deviation, PSD pattern standard deviation, N number of eyes
*T-student test (p value < 0.05). Normal distribution confirmed (Shapiro-Wilk)
†U Mann-Whitney test. No normal distribution confirmed (Shapiro-Wilk)
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A relationship between functional and structural ON
parameters in both, OSAHS and controls, was not
demonstrated. Table 4 shows linear, logarithmic, inverse,
quadratic and cubic correlation models between linear
parameters, as the thickness of peripapillary RNFL quad-
rants and parameters expressed in logarithmic scale such
as VF sensitivities.
Only the central VF sensitivity of the SAP revealed a
poor correlation with the AHI, with a Pearson’s correl-
ation coefficient of 0.284 (p = 0.024, Fig. 2).
Discussion
The low oxygen levels during sleep lead to the adrenergic
system activation, inflammation and procoagulant mecha-
nisms prompting to endothelial dysfunction, oxidative
stress and metabolic deregulation [23]. This vascular
phenomenon may compromise ON perfusion and oxygen-
ation, ultimately leading to optic neuropathy [24, 25].
Several authors, including our own group, have published
RNFL thickness variations in individuals with sleep apnea
[11–16], which could be a consequence of vascular and
gasometric alterations triggered by OSAHS.
Peripapillary RNFL thickness reflects neuronal axons,
and would allow quantification of ganglion cell axonal loss
[26]. Moreover, VF values estimates functional loss of the
whole visual pathway, from retina to cortex [27]. VF maps
show a correspondence with neuronal distribution of
RNFL in the ON head, as Garway et al. demonstrated
[17]. Therefore, theoretically, a correlation between OCT
and VF parameters could be found. If this correspondence
appears, both OCT and VF could be potentially used as
biomarkers for neuronal degeneration in OSAHS patients.
Sensitivity of superior VF division was significantly lower
in OSAHS patients than that in controls. This finding is
not consistent with a significant change of inferior peripa-
pillary RNFL thickness, which corresponds topographically
Table 3 Comparison of Humphrey visual field sensitivities and indices between controls, mild, moderate and severe OSAHS patients
Normality S-W Homogeneity Test Levene ANOVA / Kruskall W
Severity Average ± SD
[Min - Max]
p-value p-value F p-value
Average sensitivity (dB) Control (N = 38) 29.7 ± 1.3 [26.6–31.8] 0.04 0.61 / 0.2†
Mild- Moderate (N = 29) 29.1 ± 1.6 [23.9–31.1] 0.4
Severe (N = 34) 29.4 ± 1.3 [26.0–32] 0.61
VF superior division (dB) Control (N = 38) 30.1 ± 1.5 [27–32.9] 0.158 0.83 2.49 0.08*
Mild- Moderate (N = 29) 29.2 ± 1.6 [26.3–32.2] 0.7
Severe (N = 34) 29.5 ± 1.5 [25.1–32.3] 0.19
VF inferior division (dB) Control (N = 38) 31.1 ± 1.4 [27.3–33.3] 0.01 0.62 / 0.46†
Mild- Moderate (N = 29) 30.9 ± 1.3 [26.6–32.9] 0.008
Severe (N = 34) 30.9 ± 1.4 [27.6–33.7] 0.91
VF central division (dB) Control (N = 38) 27.6 ± 1.4 [23.3–31.1] 0.46 0.11 0.73 0.49*
Mild- Moderate (N = 29) 27.2 ± 1.6 [24.3–31.4] 0.49
Severe (N = 34) 27.6 ± 2.0 [24–32.1] 0.17
VF temporal division (dB) Control (N = 38) 30.2 ± 2 [25.7–33.3] 0.06 0.08 / 0.34†
Mild- Moderate (N = 29) 29.7 ± 1.9 [26.3–33] 0.03
Severe (N = 34) 29.8 ± 1.7 [25.3–33] 0.33
VFI (dB) Control (N = 38) 99.2 ± 0.8 [97–100] < 0.001 0.63 / 0.6†
Mild- Moderate (N = 29) 98.9 ± 1.0 [96–100] 0.001
Severe (N = 34) 99.0 ± 0.9 [97–100] < 0.001
MD (dB) Control (N = 38) 0.04 ± 1.1 [(−2.8) – 1.8] 0.08 0.92 1.66 0.19*
Mild- Moderate (N = 29) −0.4 ± 1.12 [(−2.5) – 1.6] 0.21
Severe (N = 34) −0.4 ± 1.2 [(−3.8) - 1.7] 0.44
PSD (dB) Control (N = 38) 1.5 ± 0.3 [0.9–2.6] 0.01 0.1 / 0.97†
Mild- Moderate (N = 29) 1.6 ± 0.9 [1.0–5.9] 0.002
Severe (N = 34) 1.6 ± 0.4 [0.9–2.8] < 0.001
VF visual field, VFI visual field index, MD mean deviation, PSD pattern standard deviation, S-W Shapiro-Wilk, Kruskall W Kruskall Wallis, N number of eyes
*ANOVA test
†Kruskal Wallis
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Table 4 Correlation models between structural and functional optic nerve variables in OSAHS patients
OSAHS (N = 63) CONTROLS (N = 38) OSAHS (N = 63) CONTROLS (N = 38)
Regression model R2 F Test (p-value) R2 F Test (p-value) R2 F Test (p-value) R2 F Test (p-value)
RNFL inferior quadrant (μm) – VF superior división (dB) RNFL Superior quadrant (μm) – VF inferior división (dB)
Lineal 0.042 0.106 0.04 0.226 0.054 0.068 0.002 0.777
Logarithmic 0.049 0.083 0.046 0.196 0.047 0.087 0.006 0.631
Inverse 0.054 0.066 0.052 0.169 0.04 0.117 0.014 0.484
Quadratic 0.076 0.095 0.067 0.294 0.071 0.11 0.054 0.376
Cubic 0.077 0.090 0.067 0.294 0.07 0.114 0.054 0.376
RNFL nasal quadrant (μm) - VF temporal división (dB) RNFL temporal quadrant (μm) - VF central división (dB)
Lineal 0.014 0.362 0.006 0.644 0.004 0.642 0.001 0.831
Logarithmic 0.008 0.48 0.01 0.547 0.005 0.580 0.003 0.76
Inverse 0.004 0.622 0.015 0.468 0.007 0.518 0.004 0.709
Quadratic 0.045 0.25 0.048 0.421 0.012 0.691 0.045 0.447
Cubic 0.055 0.339 0.05 0.62 0.012 0.691 0.052 0.393
Average RNFL (μm) – MD (dB) Average RNFL (μm) - Average sensitivity (dB)
Lineal 0.005 0,585 0.011 0.531 0.007 0.514 0.008 0.584
Logarithmic / / / / 0.008 0.489 0.01 0.557
Inverse 0.017 0.309 0.001 0.861 0.009 0.469 0.011 0.533
Quadratic 0.046 0.241 0.044 0.453 0.014 0.663 0.074 0.261
Cubic 0.061 0.291 0.046 0.658 0.014 0.66 0.075 0.255
RNFL Retinal nerve fiber layer, MD mean deviation, VF visual field. N number of eyes
Fig. 2 Pearson’s correlation coefficient (0.284, p = 0.024) between central VF sensitivity and AHI
Casas et al. BMC Ophthalmology  (2018) 18:66 Page 6 of 9
with superior VF division and would justify the functional
decline. Subtle edema secondary to vascular deregulation
and increase in cerebrospinal fluid pressure [13, 28, 29]
could explain the VF alterations found in our patients, and
the fact that reduction in sensitivity is not associated with a
decrease in RNFL thickness. As we previously suggested
[14], it is possible that analysing all ranges of OSAHS
severity together imply masking certain ON structural alter-
ations. Theoretically, a first stage of edema and inflamma-
tion in mild and intermediate stages of the respiratory
disease would precede an atrophy phase. We should, there-
fore, think that the biggest differences will be found in the
most serious cases, where the decline of the RNFL will be
triggered by longer exposure to hypoxia, and will be logical
find higher degrees of atrophy. This fact is reflected in nasal
quadrant RNFL thickness, where we found differences
between severe OSAHS and the other groups. Another
possible theory explaining the functional loss without struc-
tural alteration is the association of OSAHS with floppy
eyelid syndrome [30–32]. A fatigue-related ptosis could
reduce superior visual field acting as an artefact, as the ‘nor-
mal’ OCT inferior RNFL thickness confirms.
On the other hand, VF parameters showed no differ-
ences in the two by two comparisons between OSAHS
groups and controls. This result contrasts with those
obtained by other authors. Thus, Huseyinoglu et al. [13]
found higher PSD and lower MD values in OSAHS
patients comparing to controls. Xin et al. and Tsang et al.
[29, 33] found affected values of MD and PSD in OSAHS
comparing with controls. Nevertheless, they did not ex-
clude any case of glaucoma and that could generate a bias
in their results. Ferrandez et al. [34] found a generalized
decrease in retinal sensitivity without focal defects in
OSAHS. Furthermore, they reported changes in MD, PSD
and VFI values with worse scores in patients with apnea.
Disparities between their results and ours could be justi-
fied by different examination strategies used. We have
chosen a shorter VF strategy to explore the patients since
we know that “fatigue effect” could modify VF outcomes
[33, 35] and is more prevalent in OSAHS patients [36–
38], even when the SAP reliability criteria were kept
within normal limits. We could observe a considerable
difficulty to some OSAHS patients to maintain the con-
centration for 4 to 8 min for VF completion. Because of
this, we decided to perform SITA-fast strategies in the
present study, in spite of this shorter algorithm is known
to improve the mean defect and to be less precise com-
pared to SITA standard [39]. It is likely that hypersom-
nia, which is one of the crucial symptoms of the
disease, could act as a confounding factor during VF
examination, obtaining lower sensitivity rates compar-
ing to controls, especially in longer examinations.
Regarding structure-function analysis, the absence of a
common scale for both measurements, logarithmic on one
side (decibels) and decimal on the other one (microns or
percentages), makes it difficult to draw a parallel relationship
between both examinations. There is a controversy regard-
ing the type of association between structural and functional
variables. Thus, various publications assume a linear correl-
ation when both parameters are expressed in a linear scale,
and an exponential or curvilinear relationship when one of
the variables is linear whereas the other one is expressed in
a logarithmic scale [40, 41]. Conversely, other authors hardly
found any differences between structure-function correla-
tions when the latter was expressed in logarithmic or linear
scale [42, 43]. Based on this, our research analyses the asso-
ciation applying linear and non-linear models.
Special interest would have the correlation between
the nasal quadrant of RNFL thickness and temporal VF
division, since we found statistically significant differ-
ences for the structural parameter. Relationship between
RNFL thickness quantified with Stratus OCT and VF
MD was better fitted with second-order polynomials
than with a linear model in patients with glaucoma [41].
These regression models describe a curvilinear relation-
ship, suggesting that progression of VF loss, when it is
expressed in MD, increases during the course of the
disease. This idea is compatible with the concept of
“functional reserve”, i.e. there must be a significant
structural damage to bring up a functional representa-
tion of the same in the VF [19, 44–47]. Therefore, the
absence of correlation found in the present study may
be a consequence of the perimetric exclusion criteria, by
which all eyes with suggestive alterations of glaucomat-
ous neuropathy were excluded from the analysis.
One of the strengths of our study is that we just in-
cluded patients with normal IOP, normal gonioscopy,
and no perimetric evidence of glaucomatous neuropathy,
in order to assess a hypothetical reduction in retinal sen-
sitivity produced exclusively by the respiratory disorder.
In this way, we avoid biased results by the inclusion of
glaucomatous patients, whose incidence, as we have
already mentioned, is higher in patients suffering from
apnea [7–10]. The main limitation of our study include
the relatively small sample size, mainly when OSAHS
were divided according to severity. Groups with larger
number of patients could have shown some correlation
between variables or more consistent conclusions.
Conclusions
In conclusion, due to the lack of association between vari-
ables and no significant differences in VF variables when
dividing OSAHS patients, we cannot state that perimetry is
a useful diagnostic tool to demonstrate functional deterior-
ation in OSAHS. Moreover, future research should analyze
the results obtained in patients with OSAHS prior and after
effective treatment, to establish the real VF involvement in
the apneic disorder.
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